Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guerin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

被引：0
|
作者：
Dinney, Colin P. N. [1 ]
Narayan, Vikram M. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
[2] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA
来源：
JOURNAL OF UROLOGY | 2024年 / 212卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000004128
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design EDITORIAL COMMENTS
    Matulewicz, Richard S.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1619 - 1620
  • [22] Pembrolizumab for the Treatment of Patients With Bacillus Calmette-Guerin-Unresponsive, High-Risk Non-Muscle-Invasive Bladder Cancer: Over 2 Years' Follow-Up of KEYNOTE-057.
    Krieger, Laurence Eliot Miles
    Balar, Arjun Vasant
    Ashish, Kamat
    Kulkarni, Girish S.
    Uchio, Edward M.
    Boormans, Joost L.
    Bajorin, Dean F.
    Roumiguie, Mathieu
    Singer, Eric A.
    Grivas, Petros
    Seo, Ho Kyung
    Hiroyuki, Nishiyama
    Konety, Badrinath R.
    Zambon, Joao Paulo
    Ekta, Kapadia
    de Wit, Ronald
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 47 - 47
  • [23] INCIDENCE AND PATHOLOGIC OUTCOMES OF CYSTECTOMY IN PATIENTS WITH BACILLUS CALMETTE-GUERIN- UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU FOLLOWING TREATMENT WITH NADOFARAGENE FIRADENOVEC-VNCG
    Vikram, M. Narayan
    Stephen, Boorjian
    Paul, Crispen
    Ashish, Kamat
    Leonard, Gomella
    Max, Kates
    Lawrence, Karsh
    Viraj, Master
    Kyle, Richards
    Seth, Lerner
    Eric, Kim
    Brant, Inman
    Brian, Lane
    Anne, Schuckman
    Tracey, Krupski
    Stephen, Bardot
    Jeffrey, Montgomery
    Joseph, Busby
    Adam, Luchey
    Michael, Williams
    Piyush, Agarwal
    Dorte, Rehm
    Jorn, Jakobsen
    Kristian, Juul
    Colin, Dinney
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [24] A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guerin Refractory Nonmuscle Invasive Bladder Cancer
    McKiernan, James M.
    Barlow, LaMont J.
    Laudano, Melissa A.
    Mann, Mark J.
    Petrylak, Daniel P.
    Benson, Mitchell C.
    JOURNAL OF UROLOGY, 2011, 186 (02): : 448 - 451
  • [25] Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer
    Chamie, Karim
    Chang, Sam S.
    Kramolowsky, Eugene V.
    Gonzalgo, Mark L.
    Huang, Megan
    Bhar, Paul
    Spilman, Patricia
    Sender, Lennie
    Reddy, Sandeep K.
    Soon-Shiong, Patrick
    UROLOGY PRACTICE, 2024, 11 (02) : 367 - 375
  • [26] INTRAVESICAL ELECTROMOTIVE MITOMYCIN IN PATIENTS WITH BACILLUS CALMETTE-GUERIN-UNRESPONSIVE PRIMARY HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER: AN OPEN LABEL, SINGLE ARM, PHASE II STUDY
    Di Stasi, Savino Mauro
    Palermo, Giuseppe
    Capelli, Giovanni
    Bizzarri, Francesco Pio
    Di Stasi, Elena
    Totaro, Angelo
    Moosavi, Seyed Koosha
    Racioppi, Marco
    JOURNAL OF UROLOGY, 2024, 211 (05): : E246 - E246
  • [27] TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUERIN TREATMENT
    Alanee, Shaheen
    Montgomery, Jazzmyne
    Sana, Sherjeel
    El-Zawahry, Ahmed
    Peabody, James
    Pearce, Tiffany
    Adams, Nicole
    Deebajah, Mustafa
    Dynda, Danuta
    Babaian, Kara
    Crabtree, Jane
    Delfino, Kristin
    McVary, Kevin
    Robinson, Kathy
    Rao, Krishna
    JOURNAL OF UROLOGY, 2022, 207 (05): : E926 - E926
  • [28] EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL
    Mitra, Anirban P.
    Mokkapati, Sharada
    Miest, Tanner S.
    Narayan, Vikram M.
    Philipson, Richard
    Yla-Herttuala, Seppo
    Sawutz, David
    Parker, Nigel R.
    McConkey, David J.
    Dinney, Colin P. N.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E928
  • [29] SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guerin
    Skinner, Eila C.
    Goldman, Bryan
    Sakr, Wael A.
    Petrylak, Daniel P.
    Lenz, Heinz-Josef
    Lee, Cheryl T.
    Wilson, Shandra S.
    Benson, Mitchell
    Lerner, Seth P.
    Tangen, Cathy M.
    Thompson, Ian M.
    JOURNAL OF UROLOGY, 2013, 190 (04): : 1200 - 1204
  • [30] Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study
    Nishiyama, Naotaka
    Hotta, Hiroshi
    Takahashi, Atsushi
    Yanase, Masahiro
    Itoh, Naoki
    Tachiki, Hitoshi
    Miyao, Noriomi
    Matsukawa, Masanori
    Kunishima, Yasuharu
    Taguchi, Keisuke
    Kitamura, Hiroshi
    Masumori, Naoya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 306.e9 - 306.e15
12345